Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Jhatakia A"'
Autor:
Bezman, Natalie A. 1, *, Jhatakia, Amy 1, Kearney, Alper Y. 1, Brender, Ty 1, Maurer, Mark 1, Henning, Karla 1, Jenkins, Misty R. 2, Rogers, Amy J. 2, Neeson, Paul J. 2, Korman, Alan J. 1, Robbins, Michael D. 3, Graziano, Robert F. 4
Publikováno v:
In Blood Advances 9 May 2017 1(12):753-765
Autor:
Natalie A. Bezman, Amy Jhatakia, Alper Y. Kearney, Ty Brender, Mark Maurer, Karla Henning, Misty R. Jenkins, Amy J. Rogers, Paul J. Neeson, Alan J. Korman, Michael D. Robbins, Robert F. Graziano
Publikováno v:
Blood Advances, Vol 1, Iss 12, Pp 753-765 (2017)
Abstract: Elotuzumab, a humanized monoclonal antibody that binds human signaling lymphocytic activation molecule F7 (hSLAMF7) on myeloma cells, was developed to treat patients with multiple myeloma (MM). Elotuzumab has a dual mechanism of action that
Externí odkaz:
https://doaj.org/article/b48d5441929d44dabeefb1b6238bb93b
Autor:
Nirav S, Kapadia, Gabriel A, Brooks, Mary Beth, Landrum, Lauren, Riedel, Pang-Hsiang, Liu, Andrea, Hassol, Amanda S, Tripp, Shalini, Jhatakia, Colleen M, Kummet, Nancy L, Keating
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:39-46
Radiation utilization for breast cancer and metastatic bone disease varies in modality, fractionation, and cost, despite evidence demonstrating equal effectiveness and consensus recommendations such as Choosing Wisely that advocate for higher value c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f5a9a896c3a082b3f252ce64e36fe29
https://doi.org/10.1016/j.ijrobp.2022.01.044
https://doi.org/10.1016/j.ijrobp.2022.01.044
Autor:
Kerry S. Campbell, Adam D. Cohen, Michael D. Robbins, Natalie A. Bezman, Robert F. Graziano, Alper Y. Kearney, Amy Jhatakia, Andrew Gale, Yibin Yang, Kimberly B. Colby, Ashley M. James, Tatiana Pazina
Elotuzumab (Elo) is an IgG1 monoclonal antibody targeting SLAMF7 (CS1, CRACC, and CD319), which is highly expressed on multiple myeloma (MM) cells, natural killer (NK) cells, and subsets of other leukocytes. By engaging with FcγRIIIA (CD16), Elo pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dfd4fed3099da2d18527a6c9fd1f00e
https://doi.org/10.1158/2326-6066.c.6549927.v1
https://doi.org/10.1158/2326-6066.c.6549927.v1
Autor:
Kerry S. Campbell, Adam D. Cohen, Michael D. Robbins, Natalie A. Bezman, Robert F. Graziano, Alper Y. Kearney, Amy Jhatakia, Andrew Gale, Yibin Yang, Kimberly B. Colby, Ashley M. James, Tatiana Pazina
Supplementary Figures 1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92c1c3d238ebeff235065d4da790ca40
https://doi.org/10.1158/2326-6066.22542438.v1
https://doi.org/10.1158/2326-6066.22542438.v1
Autor:
Irene M. Ghobrial, Jamil Azzi, Michael D. Robbins, Yu-Tzu Tai, Daisy Huynh, Antonio Sacco, Chia-Jen Liu, Alexandre Detappe, Aldo Roccaro, Yuji Mishima, Michele Moschetta, Salomon Manier, Jennifer L. Guerriero, Amy Jhatakia, Natalie A. Bezman, Siobhan V. Glavey, Ahmed T. Kurdi
Supplementary Figure 1. In-vivo mouse model's schema; Supplementary Figure 2. Total BLI Flux of SCID.beige myeloma xenograft model and Kaplan-Meier survival analysis of the NSG xenograft model; Supplementary Figure 3. Elotuzumab does not affect myelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b816a97b9fef9eac8cec3db8a996da
https://doi.org/10.1158/1535-7163.22505803
https://doi.org/10.1158/1535-7163.22505803
Autor:
Irene M. Ghobrial, Jamil Azzi, Michael D. Robbins, Yu-Tzu Tai, Daisy Huynh, Antonio Sacco, Chia-Jen Liu, Alexandre Detappe, Aldo Roccaro, Yuji Mishima, Michele Moschetta, Salomon Manier, Jennifer L. Guerriero, Amy Jhatakia, Natalie A. Bezman, Siobhan V. Glavey, Ahmed T. Kurdi
Elotuzumab, a recently approved antibody for the treatment of multiple myeloma, has been shown to stimulate Fcγ receptor (FcγR)-mediated antibody-dependent cellular cytotoxicity by natural killer (NK) cells toward myeloma cells. The modulatory effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d170a9010f2820977fff9f1159ce1812
https://doi.org/10.1158/1535-7163.c.6538189.v1
https://doi.org/10.1158/1535-7163.c.6538189.v1
Autor:
Claire Friedman, Richard Carvajal, Diwakar Davar, Eduardo Castanon, Paolo Ascierto, Emiliano Calvo, Mark O'Hara, Steven Powell, Ronnie Shapira-Frommer, Elena Garralda, Daniel John Renouf, Ruth Perets, Mona Yunan, Palanikumar Ravindran, Amy Hammell, Shaun O’Brien, Ke Xu, Nicholas Wilson, Amy Jhatakia, Anandaroop Mukhopadhyay, Martin Gutierrez
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::166c628781ac35a6e708c43ad76057ad
https://doi.org/10.1136/jitc-2022-sitc2022.0592
https://doi.org/10.1136/jitc-2022-sitc2022.0592
Viral Infections and Autoimmune Disease: Roles of LCMV in Delineating Mechanisms of Immune Tolerance
Autor:
Georgia Fousteri, Amy Dave Jhatakia
Publikováno v:
Viruses, Vol 11, Iss 10, p 885 (2019)
Viral infections are a natural part of our existence. They can affect us in many ways that are the result of the interaction between the viral pathogen and our immune system. Most times, the resulting immune response is beneficial for the host. The p
Externí odkaz:
https://doaj.org/article/e828a9a46072414d91129c471079c981
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.